Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Biomaterials
|
December 6, 2016
Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF
Khandmaa Dashnyam, Guang-Zhen Jin, Joong-Hyun Kim, et al.
Cancers
|
May 8, 2020
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice
Aditi P Singh, Elaine Shum, Lakshmi Rajdev, et al.
Current Cancer Drug Targets
|
April 1, 2016
Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region
Yuanxin Liang, Jinwu Zeng, Linda Jelicks, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2015
Discovery of autophagy inhibitors with antiproliferative activity in lung and pancreatic cancer cells
Lars Ulrik Nordstrøm, Juan Sironi, Evelyn Aranda, et al.
Journal of Analytical Toxicology
|
January 13, 2016
Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program
Erick Roman Perez, Joshua A Knapp, Carl K Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines
Qun Dai, Yi-He Ling, Marie Lia, et al.
Psycho-Oncology
|
August 17, 2016
Speaking the same language: a feasibility trial for a novel visual communication tool for oncologist-patient treatment discussions
Cristian P Zanartu, Fernando J Camacho, Nicole S Nevadunski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2009
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
Tianhong Li, Liawaty Ho, Bilal Piperdi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
<sup>18</sup>F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Nitin Ohri, William R Bodner, Balazs Halmos, et al.
Plos One
|
July 29, 2016
Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer
Jin S Im, Amanda C Herrmann, Chantale Bernatchez, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Biomaterials
|
December 6, 2016
Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF
Khandmaa Dashnyam, Guang-Zhen Jin, Joong-Hyun Kim, et al.
Cancers
|
May 8, 2020
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice
Aditi P Singh, Elaine Shum, Lakshmi Rajdev, et al.
Current Cancer Drug Targets
|
April 1, 2016
Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region
Yuanxin Liang, Jinwu Zeng, Linda Jelicks, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2015
Discovery of autophagy inhibitors with antiproliferative activity in lung and pancreatic cancer cells
Lars Ulrik Nordstrøm, Juan Sironi, Evelyn Aranda, et al.
Journal of Analytical Toxicology
|
January 13, 2016
Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program
Erick Roman Perez, Joshua A Knapp, Carl K Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines
Qun Dai, Yi-He Ling, Marie Lia, et al.
Psycho-Oncology
|
August 17, 2016
Speaking the same language: a feasibility trial for a novel visual communication tool for oncologist-patient treatment discussions
Cristian P Zanartu, Fernando J Camacho, Nicole S Nevadunski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2009
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
Tianhong Li, Liawaty Ho, Bilal Piperdi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 10, 2017
<sup>18</sup>F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Nitin Ohri, William R Bodner, Balazs Halmos, et al.
Plos One
|
July 29, 2016
Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer
Jin S Im, Amanda C Herrmann, Chantale Bernatchez, et al.
Page
of 14